The testosterone levels of healthy men decline as they get older. As sleep quality and quantity typically decrease with age, objectively measured differences in the amount of sleep a healthy older man gets can affect his level of testosterone in the morning, according to a study published in the April 1st issue of the journal SLEEP.
Protein degradation and malfunction is a major cause of ageing and can be the result of attacks on proteins by other molecules. One of these processes, called glycation, involves the spontaneous attack by sugars on proteins.
Roche and CuraGen announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in high-throughput DNA sequencing.
The BMA is launching updated guidance on withholding and withdrawing life-prolonging treatment, to take into account the major changes for patients and doctors that will come into force when the Mental Capacity Act is implemented in England and Wales in April and October 2007.
The Honourable Tony Clement, Federal Minister of Health, and the Honourable George Smitherman, Health Minister of Ontario, announced that Ontario will establish a Patient Wait Times Guarantee for cataract surgery by January 1, 2009, to be supported by $205 million in federal funding.
Researchers at the University of Nottingham have joined forces with one of the world?s leading pharmaceutical companies, AstraZeneca, to single out potential medicines of the future.
Two Rutgers College of Nursing faculty members are conducting a study to develop and test a targeted intervention to reduce symptoms and improve the quality of life of patients undergoing prostate cancer treatment.
Researchers at UC San Diego have discovered that iron-containing nanoparticles being tested for use in several biomedical applications can be toxic to nerve cells and interfere with the formation of their signal-transmitting extensions.
A common asthma inhaler powered by a new propellant is safe and effective but could come at nearly triple the cost to consumers until a generic version hits the market, according to a review in today’s (March 29) New England Journal of Medicine.
The Liverpool School of Tropical Medicine has received a $23 million grant from the Bill & Melinda Gates Foundation to help victims of human filariasis — a worm infection which causes some of the world?s most debilitating and distressing diseases.